What is the CVSS score of CVE-2022-29315?

CVE-2022-29315 has a CVSS 3.1 base score of 8.8 (High). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H. EPSS exploitation probability: 1.4%.

Is there a public PoC exploit available for CVE-2022-29315?

Yes, a public proof-of-concept exploit is available for CVE-2022-29315. Prioritise patching immediately. EPSS: 1.4%.

Acunetix CVE-2022-29315

HIGH

Improper Neutralization of Formula Elements in a CSV File (CWE-1236)

2022-04-19 cve@mitre.org

Code Injection Acunetix

8.8

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

8.8 HIGH

AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

Required

Scope

Unchanged

Confidentiality

High

Integrity

High

Availability

High

Lifecycle Timeline

CVE Published

Apr 19, 2022 - 15:15 nvd

HIGH 8.8

DescriptionNVD

Invicti Acunetix before 14 allows CSV injection via the Description field on the Add Targets page, if the Export CSV feature is used.

AnalysisAI

Invicti Acunetix before 14 allows CSV injection via the Description field on the Add Targets page, if the Export CSV feature is used. Rated high severity (CVSS 8.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. Public exploit code available and no vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-1236. Invicti Acunetix before 14 allows CSV injection via the Description field on the Add Targets page, if the Export CSV feature is used. Affected products include: Invicti Acunetix. Version information: before 14.

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.